IVD Test Reagent/Kits, Immunoassay, Cardiac Marker, Protein, Atrial Natriuretic Peptide

Definition : Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a serum or plasma sample to determine atrial natriuretic peptide (ANP), a protein typically liberated from the myocardium into the blood as a result of atrial dilation or increased vascular fluid volume. ANP normalizes blood pressure and circulating blood volume by increasing the volume and the excretion of sodium in the urine (i.e., diuresis and natriuresis, respectively) and by regulating the concentrations of some hormones in blood (e.g., aldosterone, antidiuretic hormone). The level of liberated ANP is used in the diagnosis of congestive heart failure.

Entry Terms : "Atriopeptin Determination Reagents" , "Atrial Natriuretic Peptide (ANP) Determination Reagents" , "Atrial Natriuretic Factor Determination Reagents" , "ANP (Atrial Natriuretic Peptide) Determination Reagents" , "Reagents, Immunoassay, Cardiac Marker, Protein, Atrial Natriuretic Peptide"

UMDC code : 19821

U.S.companies only
Suppress Subsidiary Companies

1-1 of 1 Match(es).

Alere Inc

Company Type: Parent

Alere Inc., a global healthcare company, announced a new partnership with Population Services International as part of the "Make (+) Positive More Positive Campaign.

1-1 of 1 Match(es).


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone